Cytokines Evaluation in Early Calcineurin Inhibitors Withdrawn on Renal Transplant

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Renal Transplant RejectionImmunosuppression
Interventions
DRUG

Everolimus

Replacement of tacrolimus by everolimus, 30 days after transplat. It was done after kidney biopsy (excluding acute rejection), blood and urine analysis.

Trial Locations (1)

30150221

Santa Casa de Misericórdia de Belo Horizonte, Belo Horizonte

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Andre Barreto Pereira

OTHER

NCT01239472 - Cytokines Evaluation in Early Calcineurin Inhibitors Withdrawn on Renal Transplant | Biotech Hunter | Biotech Hunter